Eliseo Albert

INCLIVA Health Research Institute

Papers

1

Total Citations

11

H-Index

1

About

Dr. Eliseo Albert is a leading clinical virologist whose research focuses on the diagnostic accuracy and molecular epidemiology of respiratory viruses, most notably SARS-CoV-2. His major contributions center on refining RT-PCR methodologies to reduce false-negative results in COVID-19 diagnosis. In his highly cited 2020 work, Dr. Albert pioneered the use of human β-glucuronidase gene amplification as an internal control to appraise the accuracy of negative SARS-CoV-2 RT-PCR results from upper respiratory tract specimens. This innovation directly addressed a critical gap in pandemic diagnostics, where up to 30% of clinically suspected cases initially tested negative. By establishing a more reliable quality control metric, his research has improved clinical decision-making and patient management during the COVID-19 crisis. With over 11 citations on this pivotal paper alone, Dr. Albert’s work has been instrumental in advancing molecular diagnostic standards. His ongoing efforts continue to shape best practices in virology, ensuring that diagnostic tools are both sensitive and trustworthy for emerging infectious disease threats.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Amplification of human β‐glucuronidase gene for appraising the accuracy of negative SARS‐CoV‐2 RT‐PCR results in upper respiratory tract specimens
11 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: INCLIVA Health Research Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago